Literature DB >> 26798639

Corrigendum to "Strategy for the Management of Diabetic Macular Edema: The European Vitreo-Retinal Society Macular Edema Study".

Ron A Adelman1, Aaron J Parnes2, Zofia Michalewska3, Barbara Parolini4, Claude Boscher5, Didier Ducournau6.   

Abstract

Entities:  

Year:  2015        PMID: 26798639      PMCID: PMC4698543          DOI: 10.1155/2015/694902

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


× No keyword cloud information.
Through this corrigendum, the authors declare that the EVRS Macular Edema Study Group is a coauthor of the paper entitled “Strategy for the Management of Diabetic Macular Edema: The European Vitreo-Retinal Society Macular Edema Study” [1]. The names of “Ron Adelman” and “Aaron Parnes” are corrected.
  1 in total

1.  Strategy for the management of diabetic macular edema: the European vitreo-retinal society macular edema study.

Authors:  Ron Adelman; Aaron Parnes; Zofia Michalewska; Barbara Parolini; Claude Boscher; Didier Ducournau
Journal:  Biomed Res Int       Date:  2015-01-28       Impact factor: 3.411

  1 in total
  3 in total

Review 1.  Management of diabetic macular edema in Japan: a review and expert opinion.

Authors:  Hiroko Terasaki; Yuichiro Ogura; Shigehiko Kitano; Taiji Sakamoto; Toshinori Murata; Akito Hirakata; Tatsuro Ishibashi
Journal:  Jpn J Ophthalmol       Date:  2017-12-05       Impact factor: 2.447

Review 2.  Surgical Innovations in the Treatment of Diabetic Macular Edema and Diabetic Retinopathy.

Authors:  Maria H Berrocal; Luis A Acaba; Megan L Chenworth
Journal:  Curr Diab Rep       Date:  2019-09-16       Impact factor: 4.810

3.  Biomarkers and predictors for functional and anatomic outcomes for small gauge pars plana vitrectomy and peeling of the internal limiting membrane in naïve diabetic macular edema: The VITAL Study.

Authors:  Matias Iglicki; Alejandro Lavaque; Malgorzata Ozimek; Hermino Pablo Negri; Mali Okada; Jay Chhablani; Catharina Busch; Anat Loewenstein; Dinah Zur
Journal:  PLoS One       Date:  2018-07-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.